|
Volumn 65, Issue 12, 1999, Pages 1287-1296
|
Troglitazone can prevent development of Type 1 diabetes induced by multiple low-dose streptozotocin in mice
|
Author keywords
IL 1 ; TNF ; Troglitazone; Type 1 diabetes
|
Indexed keywords
INTERLEUKIN 1 DERIVATIVE;
STREPTOZOCIN;
TROGLITAZONE;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CELL VIABILITY;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DRUG MECHANISM;
HYPERGLYCEMIA;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN RELEASE;
INSULITIS;
MOUSE;
NONHUMAN;
ANIMALS;
BLOOD GLUCOSE;
CHROMANS;
CRICETINAE;
DIABETES MELLITUS, EXPERIMENTAL;
DIABETES MELLITUS, TYPE 1;
FREE RADICAL SCAVENGERS;
HYPOGLYCEMIC AGENTS;
INSULIN;
ISLETS OF LANGERHANS;
MICE;
MICE, INBRED DBA;
NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE TYPE II;
STREPTOZOCIN;
THIAZOLES;
THIAZOLIDINEDIONES;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0033551892
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/S0024-3205(99)00364-1 Document Type: Article |
Times cited : (28)
|
References (30)
|